Splenic volume as a predictor of survival in cancer patients treated with immune checkpoint inhibitors
A higher baseline spleen volume and an increase in spleen volume during ICI therapy were predictors of a poor prognosis in cancer patients treated with ICI.
Authors
- Qing Zhou (ORCID: https://orcid.org/0000-0002-1917-5105)
- Xin Fu (ORCID: https://orcid.org/0009-0001-7478-0244)
- Weixing Wang (ORCID: https://orcid.org/0000-0001-7044-2275)
- Yunhua Zhang (ORCID: https://orcid.org/0000-0003-0522-1497)
- Lilong Zhang
Institutions
- Wuhan University (CN)
- Renmin Hospital of Wuhan University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-05-30
- DOI
- https://doi.org/10.3389/fimmu.2025.1598484
- Citations
- 4
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 4.18